MX2023000105A - Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19. - Google Patents

Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19.

Info

Publication number
MX2023000105A
MX2023000105A MX2023000105A MX2023000105A MX2023000105A MX 2023000105 A MX2023000105 A MX 2023000105A MX 2023000105 A MX2023000105 A MX 2023000105A MX 2023000105 A MX2023000105 A MX 2023000105A MX 2023000105 A MX2023000105 A MX 2023000105A
Authority
MX
Mexico
Prior art keywords
covid
predicting
methods
respiratory pathogens
related outcomes
Prior art date
Application number
MX2023000105A
Other languages
English (en)
Inventor
Kathleen Barnes
Ivana Yang
Christopher Gignoux
Rasika Mathias
Paul Norman
Alem Taye
Rishi Porecha
Bret Barnes
Brett Peterson
Original Assignee
Univ Colorado Regents
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Colorado Regents filed Critical Univ Colorado Regents
Publication of MX2023000105A publication Critical patent/MX2023000105A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Abstract

El concepto de la invención proporciona una plataforma basada en la metilación del ADN, y algoritmos de aprendizaje automático, para diagnosticar patógenos respiratorios que incluyen SARS-CoV-2 y predecir los resultados relacionados con el COVID-19, y métodos para usarlos, tales como identificar la presencia de una infección viral, tal como una infección por SARS-CoV-2, determinar si un sujeto tiene COVID-19, y/o si un sujeto con COVID-19 tiene probabilidad de desarrollar el síndrome de dificultad respiratoria aguda o síndrome inflamatorio multisistema en niños.
MX2023000105A 2020-06-23 2021-06-23 Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19. MX2023000105A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063042669P 2020-06-23 2020-06-23
PCT/US2021/038763 WO2021262894A1 (en) 2020-06-23 2021-06-23 Methods for diagnosing respiratory pathogens and predicting covid-19 related outcomes

Publications (1)

Publication Number Publication Date
MX2023000105A true MX2023000105A (es) 2023-04-25

Family

ID=79281779

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023000105A MX2023000105A (es) 2020-06-23 2021-06-23 Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19.

Country Status (10)

Country Link
US (1) US20240093318A1 (es)
EP (1) EP4168593A1 (es)
JP (1) JP2023532444A (es)
KR (1) KR20230038486A (es)
CN (1) CN116096920A (es)
AU (1) AU2021297245A1 (es)
BR (1) BR112022026509A2 (es)
CA (1) CA3184128A1 (es)
MX (1) MX2023000105A (es)
WO (1) WO2021262894A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4303326A1 (fr) * 2022-07-06 2024-01-10 Biomérieux Determination du risque de deces d'un sujet infecte par un virus respiratoire par mesure du niveau d'expression du gene oas2
WO2024008955A1 (en) * 2022-07-08 2024-01-11 Age Labs As Method of screening for severe covid-19 susceptibility

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023230A1 (en) * 2000-06-30 2004-02-05 Alexander Olek Method and nucleic acids for pharmacogenomic methylation analysis
BR112019018272A2 (pt) * 2017-03-02 2020-07-28 Youhealth Oncotech, Limited marcadores metilação para diagnosticar hepatocelular carcinoma e câncer

Also Published As

Publication number Publication date
US20240093318A1 (en) 2024-03-21
WO2021262894A1 (en) 2021-12-30
KR20230038486A (ko) 2023-03-20
EP4168593A1 (en) 2023-04-26
BR112022026509A2 (pt) 2023-03-07
JP2023532444A (ja) 2023-07-28
CN116096920A (zh) 2023-05-09
CA3184128A1 (en) 2021-12-30
AU2021297245A1 (en) 2023-02-02

Similar Documents

Publication Publication Date Title
MX2023000105A (es) Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19.
EP2576833A4 (en) METHOD AND DEVICE FOR THE POINT-OF-CARE DETECTION OF NUCLEIC ACID IN A SAMPLE
IN2014DN06795A (es)
GB2499519B (en) User presence detection and event discovery
BR112015012297A2 (pt) conexões implícitas de gráfico social
CL2019002787A1 (es) Método y sistema para la evaluación del aliento de un paciente para determinar la concentración de diversos. (divisional solicitud 201800570)
UA101353C2 (ru) Способ контроля конвейерной ленты и устройство для его осуществления
JP2011210179A5 (es)
WO2020051452A3 (en) Hiv or hcv detection with crispr-cas13a
CR20140188A (es) Extractor y método de artículo moldeado
MX357457B (es) Metodo para evaluar la integridad de la pared celular bacteriana.
CA3056911A1 (en) Methods for diagnosing and treating inflammatory bowel disease
WO2013028544A3 (en) Compositions and methods for detecting and discriminating between yeast or mold
WO2016168359A8 (en) Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions
GB2568854A (en) Methods for automated controversy detection of content
GB2462218A (en) Subject modelling
IN2013CH01324A (es)
TW201613017A (en) Method for rejecting tuning disturbances to improve lamp failure prediction quality in thermal processes
Grzebyk et al. Phenotypic evaluation of hydrophobicity and the ability to produce biofilm in coagulase-negative staphylococci isolated from infected very-low-birthweight newborns
董奎勇 et al. A worsted yarn virtual production system based on BP neural network
MX2022011811A (es) Metodos y tratamiento con exceso de light libre.
Durga et al. The effect of phototherapy on serum ionized calcium levels in neonates with unconjugated hyper bilirubinemia
PH12016502392A1 (en) Process for enchancing the melt strength of polypropylene
孙胜男 The analysis of correlation between serum procalcitonin concentration and microbial infectionsin patients with sepsis
MX2017004816A (es) Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa.